Does CBN Lower Blood Pressure?
Research on CBN and blood pressure specifically is very limited. Cannabinoids as a class have documented vasodilatory effects, and CBN shares some of these properties through CB1 receptor activity, but there is no strong clinical evidence that CBN meaningfully lowers blood pressure at typical supplement doses.
Cannabis and blood pressure research is better established for THC and CBD than for CBN. THC produces acute vasodilation through CB1 receptor activity, which can temporarily reduce it. CBD has some evidence for modest reduction through different mechanisms. CBN, as a weaker CB1 agonist than THC, may produce mild vasodilatory effects but the clinical evidence is not strong enough to make confident claims. Most of what is known comes from preclinical research and extrapolation from the broader cannabinoid literature rather than human trials specifically on CBN.
Drug interaction is more clinically relevant here than any direct effect on blood pressure itself. CBN, like CBD, inhibits certain CYP450 liver enzymes involved in metabolizing many medications, including some antihypertensives. This can alter how those medications are processed, potentially raising or lowering their effective concentration. Anyone taking prescription medication for hypertension should discuss CBN use with a physician before starting.
This content is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the FDA. TribeTokes products are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before using cannabinoid products, especially if you take prescription medications.